menu
    • menu

    Company profile for Oncorus

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Welcome to Oncorus. We are a biopharmaceutical company focused on developing next-generation viral immunotherapies to transform outcomes for cancer patients. While immunotherapies have improved outcomes for some patients, many patients unfortunately are not eligible for, or do not respond to, existing immunotherapies. At Oncorus, our goal is to enable more patients to respond to this revolutionary approach of harnessing the...
    Welcome to Oncorus. We are a biopharmaceutical company focused on developing next-generation viral immunotherapies to transform outcomes for cancer patients. While immunotherapies have improved outcomes for some patients, many patients unfortunately are not eligible for, or do not respond to, existing immunotherapies. At Oncorus, our goal is to enable more patients to respond to this revolutionary approach of harnessing the body’s immune system to tackle cancer. We are advancing a pipeline of intratumorally and intravenously administered product candidates for multiple indications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OncorusUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    50 Hampshire Street Suite 401 Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oncorus.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oncorus-inc.
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/oncorusinc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oncorus liquidates a week after shedding workforce
    Oncorus liquidates a week after shedding workforce

    12 Jun 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/after-layoffs-leave-oncorus-shell-company-biotechs-board-liquidates-business

    James Waldron FIERCE BIOTECH
    12 Jun 2023
    Share Share
    Facing bankruptcy, Oncorus lays off 'substantially' all staff
    Facing bankruptcy, Oncorus lays off 'substantially' all staff

    02 Jun 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/facing-bankruptcy-rna-focused-oncorus-lays-substantially-all-its-staff

    James Waldron FIERCE BIOTECH
    02 Jun 2023
    Share Share
    Oncorus Announces Workforce Reduction Plan
    Oncorus Announces Workforce Reduction Plan

    01 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/01/2680823/0/en/Oncorus-Announces-Workforce-Reduction-Plan.html

    GLOBENEWSWIRE
    01 Jun 2023
    Share Share
    Oncorus Reports First Quarter 2023 Financial Results & Provides Business Updates
    Oncorus Reports First Quarter 2023 Financial Results & Provides Business Updates

    22 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/22/2673793/0/en/Oncorus-Reports-First-Quarter-2023-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    22 May 2023
    Share Share
    Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results
    Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results

    24 Mar 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/03/24/2633875/0/en/Oncorus-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    24 Mar 2023
    Share Share
    Oncorus to collaborate with Daewoong for Lipid Nanoparticle Formulations
    Oncorus to collaborate with Daewoong for Lipid Nanoparticle Formulations

    04 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/01/04/2582758/0/en/Oncorus-Announces-Research-Collaboration-with-Daewoong-Pharmaceutical-for-the-Development-of-Lipid-Nanoparticle-Formulations-for-mRNA-Drug-Candidates.html

    GLOBENEWSWIRE
    04 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search